U.S. President Joe Biden speaks on prescription drug pricing in the East Room of the White House in Washington, D.C., U.S., on Monday, Dec. 6, 2021. Biden is looking to sell his economic agenda to the public this week, speaking today about how his tax and spending plan aims to reduce the cost of prescription drugs. Photo: Stefani Reynolds/Bloomberg
Too progressive. Too moderate. Bad for workers.
The whispers and background chatter about top contenders for the Supreme Court are growing as President Joe Biden zeroes in on a nominee to replace retiring Justice Stephen Breyer. And while the president is eager for input, the White House insists he’s not going to be swayed by any sniping.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
